Quick Answer
Exousia Bio, Inc. reported Shares Outstanding of 7.78 million shares for fiscal year 2025.
Exousia Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 7.78M | +0.0% |
| 2024 | 7.78M | +0.0% |
| 2023 | 7.78M | +55.5% |
| 2022 | 5.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | 70.00M | +800.1% | +800.1% |
| August 31, 2025 | 7.78M | +0.0% | +0.0% |
| May 31, 2025 | 7.78M | +0.0% | +0.0% |
| February 28, 2025 | 7.78M | +0.0% | +0.0% |
| November 30, 2024 | 7.78M | +0.0% | +0.0% |
| August 31, 2024 | 7.78M | +0.0% | +0.0% |
| May 31, 2024 | 7.78M | +0.0% | +0.0% |
| February 29, 2024 | 7.78M | +46.7% | +0.0% |
- Exousia Bio, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Exousia Bio, Inc.’s shares outstanding has grown by 55.5% (from 5.00 million shares to 7.78 million shares).
- The most recent figure is from Exousia Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: